Document And Entity Information |
Mar. 16, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Document Period End Date | Mar. 16, 2023 |
| Entity Registrant Name | JANONE INC. |
| Entity Central Index Key | 0000862861 |
| Amendment Description | On March 15, 2023, JanOne Inc. (the “Company”) announced that it had entered into an agreement to dispose of three of its subsidiaries. The following day (March 16, 2023), the Company and the prospective purchaser of the subsidiaries determined that certain fundamental transaction issues in respect of the announced disposition remained open and that, therefore, the Company could not have consummated the transactions contemplated by the agreement, which agreement, at that time, also did not bind the Company. Nevertheless, the Company retains its expectation that it will become a “pure biopharma” enterprise. In that regard, the Company has undertaken a series of steps in anticipation of effectuating such a potential disposition, the economic terms of which the Company anticipates may be as or more favorable than the terms of the unenforceable transaction. |
| Entity Emerging Growth Company | false |
| Entity File Number | 000-19621 |
| Entity Incorporation, State or Country Code | NV |
| Entity Tax Identification Number | 41-1454591 |
| Entity Address, Address Line One | 325 E. Warm Springs Road, Suite 102 |
| Entity Address, City or Town | Las Vegas |
| Entity Address, State or Province | NV |
| Entity Address, Postal Zip Code | 89119 |
| City Area Code | 702 |
| Local Phone Number | 997-5968 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value per share |
| Trading Symbol | JAN |
| Security Exchange Name | NASDAQ |